Insiders Buying Black Diamond Therapeutics Might Wish They Invested More, Stock Gains 10%

Written by on September 2, 2023

Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) insiders who bought shares over the past year were rewarded handsomely last week. The stock rose 10%, resulting in a US$17m rise in the company's market capitalisation. As a result, their original purchase of US$72k worth of stock is now worth US$201k.

Although we don't think shareholders should simply follow . . .



Current track

Title

Artist